ATE281156T1 - Verfahren zur herstellung eines tabletts mit kontrollierter freisetzung mit der verwendung von einem porenbildenden agens in der beschichtung - Google Patents

Verfahren zur herstellung eines tabletts mit kontrollierter freisetzung mit der verwendung von einem porenbildenden agens in der beschichtung

Info

Publication number: ATE281156T1
Authority: AT; Austria
Prior art keywords: pore; forming agent; coating; producing; controlled release
Prior art date: 2000-03-31

Application number

AT01914312T

Other languages

English (en)

Inventor

John Kendrup

Peter Fyhr

Original Assignee

Amarin Dev Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-31

Filing date

2001-03-23

Publication date

2004-11-15

2001-03-23 Application filed by Amarin Dev Ab filed Critical Amarin Dev Ab

2004-11-15 Application granted granted Critical

2004-11-15 Publication of ATE281156T1 publication Critical patent/ATE281156T1/de

Links

239000003795 chemical substances by application Substances 0.000 title abstract 3
239000011248 coating agent Substances 0.000 title abstract 3
238000000576 coating method Methods 0.000 title abstract 3
238000013270 controlled release Methods 0.000 title abstract 2
238000004519 manufacturing process Methods 0.000 title 1
CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 abstract 2
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract 1
UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 abstract 1
229930010555 Inosine Natural products 0.000 abstract 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 1
235000003704 aspartic acid Nutrition 0.000 abstract 1
229960005261 aspartic acid Drugs 0.000 abstract 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 abstract 1
229960003624 creatine Drugs 0.000 abstract 1
239000006046 creatine Substances 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
235000013922 glutamic acid Nutrition 0.000 abstract 1
229960002989 glutamic acid Drugs 0.000 abstract 1
239000004220 glutamic acid Substances 0.000 abstract 1
229960003786 inosine Drugs 0.000 abstract 1
235000016337 monopotassium tartrate Nutrition 0.000 abstract 1
239000002245 particle Substances 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1
KYKNRZGSIGMXFH-ZVGUSBNCSA-M potassium bitartrate Chemical compound [K+].OC(=O)[C@H](O)[C@@H](O)C([O-])=O KYKNRZGSIGMXFH-ZVGUSBNCSA-M 0.000 abstract 1
229940081543 potassium bitartrate Drugs 0.000 abstract 1
239000007787 solid Substances 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
229920003176 water-insoluble polymer Polymers 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates

Landscapes

Health & Medical Sciences (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT01914312T 2000-03-31 2001-03-23 Verfahren zur herstellung eines tabletts mit kontrollierter freisetzung mit der verwendung von einem porenbildenden agens in der beschichtung ATE281156T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE0001151A SE0001151D0 (sv)	2000-03-31	2000-03-31	Method for producing a controlled-release composition
PCT/SE2001/000626 WO2001074336A1 (en)	2000-03-31	2001-03-23	Method for producing a controlled-release preparation

Publications (1)

Publication Number	Publication Date
ATE281156T1 true ATE281156T1 (de)	2004-11-15

Family

ID=20279094

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01914312T ATE281156T1 (de)	2000-03-31	2001-03-23	Verfahren zur herstellung eines tabletts mit kontrollierter freisetzung mit der verwendung von einem porenbildenden agens in der beschichtung

Country Status (8)

Country	Link
US (2)	US6974591B2 (de)
EP (2)	EP1516616A1 (de)
JP (1)	JP4963767B2 (de)
AT (1)	ATE281156T1 (de)
AU (1)	AU2001239658A1 (de)
DE (1)	DE60106889T2 (de)
SE (1)	SE0001151D0 (de)
WO (1)	WO2001074336A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6551617B1 (en) *	2000-04-20	2003-04-22	Bristol-Myers Squibb Company	Taste masking coating composition
CA2359812C (en)	2000-11-20	2004-02-10	The Procter & Gamble Company	Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US20030175349A1 (en) *	2001-01-30	2003-09-18	Council Of Scientific And Industrial Research	Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient
US6960357B2 (en)	2001-05-25	2005-11-01	Mistral Pharma Inc.	Chemical delivery device
US8084058B2 (en)	2002-09-20	2011-12-27	Watson Pharmaceuticals, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en)	2002-09-20	2010-08-31	Watson Pharmaceuticals, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7959946B2 (en)	2002-09-20	2011-06-14	Watson Pharmaceuticals, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
KR20120034211A (ko) *	2002-09-20	2012-04-10	안드렉스 랩스 엘엘씨	약제학적 정제
US9060941B2 (en)	2002-09-20	2015-06-23	Actavis, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
GB0518579D0 (en) *	2005-09-12	2005-10-19	Cr Technologies Llp	Controlled delivery creatine formulations and method of using the same
RU2408368C2 (ru)	2005-06-27	2011-01-10	Биовэйл Лэборэториз Интернэшнл С.Р.Л.	Препараты соли бупропиона с модифицированным высвобождением
ATE536867T1 (de)	2006-03-16	2011-12-15	Tris Pharma Inc	Modifizierte freisetzungsformulierungen mit arznei-ion-austausch-harzkomplexen
TW200815045A (en) *	2006-06-29	2008-04-01	Jazz Pharmaceuticals Inc	Pharmaceutical compositions of ropinirole and methods of use thereof
DE102006030860A1 (de) *	2006-07-04	2008-01-10	Universität Regensburg	Oligomere von Isonitril-Metallkomplexen als Triplett-Emitter für OLED-Anwendungen
CN101766581B (zh) *	2008-12-30	2012-08-15	北京科信必成医药科技发展有限公司	一种群孔释放的盐酸地尔硫卓择时控释片及其制备方法
RU2559083C9 (ru)	2009-05-19	2016-01-20	Неуродерм Лтд	Композиции для непрерывного введения ингибиторов допа-декарбоксилазы
WO2011041414A1 (en)	2009-09-30	2011-04-07	Acura Pharmaceuticals, Inc.	Methods and compositions for deterring abuse
US8623409B1 (en)	2010-10-20	2014-01-07	Tris Pharma Inc.	Clonidine formulation
CN110123743A (zh)	2010-11-15	2019-08-16	纽罗德姆有限公司	L-多巴、多巴脱羧酶抑制剂、儿茶酚-o-甲基转移酶抑制剂及其组合物的连续施用
EP2481411A1 (de) *	2011-01-27	2012-08-01	Ratiopharm GmbH	Orale Dosierformen für modifizierte Freisetzung mit dem JAK3-Hemmer tasocitinib
WO2013183055A1 (en)	2012-06-05	2013-12-12	Neuroderm Ltd	Compositions comprising apomorphine and organic acids and uses thereof
WO2014011830A1 (en)	2012-07-12	2014-01-16	Mallinckrodt Llc	Extended release, abuse deterrent pharmaceutical compositions
AU2013302657B2 (en)	2012-08-15	2018-08-09	Tris Pharma, Inc.	Methylphenidate extended release chewable tablet
EP3116475B1 (de)	2014-03-13	2020-11-04	Neuroderm Ltd	Dopa-decarboxylasehemmerzusammensetzungen
US10258585B2 (en)	2014-03-13	2019-04-16	Neuroderm, Ltd.	DOPA decarboxylase inhibitor compositions
US11590228B1 (en)	2015-09-08	2023-02-28	Tris Pharma, Inc	Extended release amphetamine compositions
US11590081B1 (en)	2017-09-24	2023-02-28	Tris Pharma, Inc	Extended release amphetamine tablets
US12458592B1 (en)	2017-09-24	2025-11-04	Tris Pharma, Inc.	Extended release amphetamine tablets
WO2020128062A1 (en) *	2018-12-21	2020-06-25	Re-Vana Therapeutics Ltd	Ocular compositions
WO2021171972A1 (ja) *	2020-02-28	2021-09-02	株式会社Ｓｃｒｅｅｎホールディングス	固体製剤
US11918689B1 (en)	2020-07-28	2024-03-05	Tris Pharma Inc	Liquid clonidine extended release composition
US11844754B2 (en)	2020-11-17	2023-12-19	Neuroderm, Ltd.	Methods for treatment of Parkinson's disease
US11213502B1 (en)	2020-11-17	2022-01-04	Neuroderm, Ltd.	Method for treatment of parkinson's disease
US11331293B1 (en)	2020-11-17	2022-05-17	Neuroderm, Ltd.	Method for treatment of Parkinson's disease
US12161612B2 (en)	2023-04-14	2024-12-10	Neuroderm, Ltd.	Methods and compositions for reducing symptoms of Parkinson's disease

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
USB587055I5 (de) *	1956-05-24
US4557925A (en)	1982-07-08	1985-12-10	Ab Ferrosan	Membrane-coated sustained-release tablets and method
US4629619A (en) *	1984-09-05	1986-12-16	Ab Ferrosan	Membrane-coated sustained-release tablets and method
SE8803822D0 (sv) *	1988-10-26	1988-10-26		Novel dosage form
US5376383A (en)	1988-11-21	1994-12-27	Merck & Co., Inc.	Method for enhancing the lowering of plasma-cholesterol levels
US5126146A (en) *	1989-10-23	1992-06-30	Merck & Co., Inc.	Cellulosic coating
US5472712A (en) *	1991-12-24	1995-12-05	Euroceltique, S.A.	Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5580578A (en) *	1992-01-27	1996-12-03	Euro-Celtique, S.A.	Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5324351A (en) *	1992-08-13	1994-06-28	Euroceltique	Aqueous dispersions of zein and preparation thereof
US5500227A (en) *	1993-11-23	1996-03-19	Euro-Celtique, S.A.	Immediate release tablet cores of insoluble drugs having sustained-release coating
US6207190B1 (en) *	1998-08-13	2001-03-27	Chronorx, Llc	Dosage forms for the treatment of the chronic glaucomas

2000
- 2000-03-31 SE SE0001151A patent/SE0001151D0/xx unknown
2001
- 2001-03-23 WO PCT/SE2001/000626 patent/WO2001074336A1/en not_active Ceased
- 2001-03-23 AU AU2001239658A patent/AU2001239658A1/en not_active Abandoned
- 2001-03-23 EP EP04025989A patent/EP1516616A1/de not_active Withdrawn
- 2001-03-23 DE DE60106889T patent/DE60106889T2/de not_active Expired - Lifetime
- 2001-03-23 JP JP2001572081A patent/JP4963767B2/ja not_active Expired - Fee Related
- 2001-03-23 AT AT01914312T patent/ATE281156T1/de not_active IP Right Cessation
- 2001-03-23 EP EP01914312A patent/EP1267842B1/de not_active Expired - Lifetime
- 2001-03-29 US US09/819,813 patent/US6974591B2/en not_active Expired - Fee Related
2005
- 2005-10-19 US US11/255,073 patent/US20060159755A1/en not_active Abandoned

Also Published As

Publication number	Publication date
SE0001151D0 (sv)	2000-03-31
JP4963767B2 (ja)	2012-06-27
WO2001074336A1 (en)	2001-10-11
EP1267842A1 (de)	2003-01-02
DE60106889D1 (de)	2004-12-09
US20060159755A1 (en)	2006-07-20
AU2001239658A1 (en)	2001-10-15
EP1516616A1 (de)	2005-03-23
DE60106889T2 (de)	2006-03-23
JP2003528910A (ja)	2003-09-30
EP1267842B1 (de)	2004-11-03
US20010038853A1 (en)	2001-11-08
US6974591B2 (en)	2005-12-13

Legal Events

Date	Code	Title	Description
2005-05-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE60106889D1 (de)	2004-12-09	Verfahren zur herstellung eines tabletts mit kontrollierter freisetzung mit der verwendung von einem porenbildenden agens in der beschichtung
DE60034565D1 (de)	2007-06-06	Verfahren zur herstellung eines umhüllten geschmackmaskierten granulats mit sofortiger wirkstofffreisetzung
DK164256C (da)	1992-10-19	Praeparat med kontrolleret afgivelse og fremgangsmaade til fremstilling heraf
DE69519664D1 (de)	2001-01-25	Verfahren zur herstellung fester pharmazeutischer dosierungsform
DE69840495D1 (de)	2009-03-12	Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben
TW200510939A (en)	2005-03-16	Preparation of polymer and resist composition
KR910011242A (ko)	1991-08-07	서방성 약학제제 및 그의 제조방법
NO172276C (no)	1993-06-30	Fremgangsmaate for fremstilling av et farmasoeytisk preparat med regulert frigjoering
ATE220898T1 (de)	2002-08-15	Nifedipinzubereitung mit langanhaltender freisetzung
DE59309513D1 (de)	1999-05-20	Verfahren zur Herstellung von Polysuccinimid, Polyasparaginsäure und ihrer Salze
EP0377517A3 (de)	1990-10-24	Theophyllin-Dosisform
ATE375729T1 (de)	2007-11-15	Verfahren zur herstellung eines pharmazeutischen kaugummis
ATE327737T1 (de)	2006-06-15	Verfahren zur herstellung von arzneistoffgranulatkörnern, die arzneistoffgranulatkörner sowie diese enthaltende pharmazeutische zubereitungen
DE69616072D1 (de)	2001-11-22	Stabile feste formulierung eines enalaprilsalzes und verfahren zu deren herstellung
DE60022332D1 (de)	2005-10-06	Ketoprofen mikrogranulat, verfahren zur herstellung desselben sowie pharmazeutische zusammensetzungen
ATE214598T1 (de)	2002-04-15	Multipartikuläre pharmazeutische form mit gesteuerter und gepulster wirkstoffabgabe und verfahren zu deren herstellung
DK575688D0 (da)	1988-10-14	Farmaceutisk praeparat med kontrolleret absorption af diltiazem og fremgangsmaade til fremstilling deraf
DE60042972D1 (de)	2009-10-29	Trimetazidine enthaltendes Arzneimittel mit verzögerter Wirkstoffabgabe und Verfahren zur Herstellung
ATE461226T1 (de)	2010-04-15	Verfahren zur herstellung von polyacrolein
EP1258254A4 (de)	2004-02-04	Zusammensetzungen zur verzögerten abgabe von physiologisch aktiven verbindungen die kaum wasserlösslich sind, verfahren zu deren herstellung und deren verwendung
ATE444731T1 (de)	2009-10-15	Geschmacksmaskierte beschichtete teilchen, verfahren zur herstellung und in der mundhöhle dispergierbare tabletten enthaltend die beschichteten teilchen
DK1417960T3 (da)	2012-02-20	Mikropellets med vedvarende frisætning og fremgangsmåde til fremstilling heraf
ATE193297T1 (de)	2000-06-15	Wasserlösliche derivate epipodophyllotoxine, verfahren zu ihrer herstellung, ihre verwendung als medikament und ihre verwendung zur herstellung eines antikrebsmittels
DE69007294D1 (de)	1994-04-14	Verfahren zur herstellung eines aktiven feinen zuschlagstoffes zur betonherstellung.
DE60125226D1 (de)	2007-01-25	Verfahren zur herstellung von partikelförmigen polymerisaten